CompoAtlas

Eye Health Formula

Natural health product licensed in Canada

Other names
Eye Health
Licence holder
GNC Canada Holdings ULC
NPN or DIN-HM
80042497
Status
Inactive licence
Licence date
28 May 2013
Revision date
6 April 2016
Form
Gélule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Huile de poisson

Source : Huile de corps

Potency : 152 mg EPA

525 mgNot calculated
L-glutathion25 mgNot calculated
Huile de poisson

Source : Huile de corps

Potency : 105 mg DHA

Not specifiedNot calculated
Huile de poisson

Source : Anchois et/ou sardine et/ou maquereau

Potency : 152 mg EPA

525 mgNot calculated
Huile de poisson

Source : Anchois et/ou sardine et/ou maquereau

Potency : 105 mg DHA

Not specifiedNot calculated
Vaccinium myrtillus

Source : Fruit

80 mgNot calculated

Non-medicinal ingredients

Dioxyde de silicium, Gélatine, Lécithine, Glycérine, Huile de soja, Cire d'abeille, Caramel

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years2 Gélule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps to maintain eyesight. Helps to maintain skin membranes. Helps to maintain immune function. Helps in the development and maintenance of night vision. Helps in the development and maintenance of bones and teeth. Provides antioxidants for the maintenance of eye health. Helps to support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to reduce the risk of developing cataracts. Helps to improve macular pigment optical density.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80042497

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2016. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2016. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line